Get started
Author

E. V. Borodavina

Observed names: E Borodavina, E. Borodavina, E.V. Borodavina, Бородавина Е.В., Бородавина Екатерина Владимировна, Е. В. Бородавина, Е.В. Бородавина, Екатерина Бородавина
ORCID: 0000-0002-3306-5906
Observed ORCID: 0000-0002-3306-5906
OpenAlex ID: A5080936660
Draft of clinical guidelines for the diagnosis and treatment of differentiated thyroid cancer in adult patients
2023 · E. L. Choinzonov, I. V. Reshetov, et al. · Endocrine Surgery · 12
PDF
Radioiodine Ablation for Thyroid Cancer. Historical and Modern Aspects. Literature Review
2021 · A. Yu. Shurinov, V. V. Krylov, et al. · Journal of oncology diagnostic radiology and radiotherapy · 8
PDF
Draft of clinical guidelines for the diagnosis and treatment of medullary thyroid cancer in adult patients
2023 · N. V. Severskaya, E. L. Choinzonov, et al. · Endocrine Surgery · 6
PDF
Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation
2020 · E. V. Borodavina, P. A. Isaev, et al. · Head and neck tumors (HNT) · 6
PDF
Guidelines for radioiodine therapy in differentiated thyroid cancer and post-therapeutic follow-up
2024 · A. Yu. Shurinov, E. V. Borodavina, et al. · Head and neck tumors (HNT) · 4
PDF
Follow-up after radioiodine remnant ablation in differentiated thyroid cancer: the view of nuclear medicine physician
2023 · A. Yu. Shurinov, E. V. Borodavina · Head and neck tumors (HNT) · 2
PDF
Side effects of skin toxicity in targeted therapy of malignant neoplasms (literature review)
2022 · Екатерина Бородавина, Павел Исаев, et al. · Voprosy Onkologii · 2
PDF
Survival analysis of patients with advanced metastatic differentiated thyroid cancer
2022 · E. V. Borodavina, A. Yu. Shurinov, et al. · Head and neck tumors (HNT) · 2
PDF
Historical aspects and modern concepts in the treatment of patients with differentiated thyroid cancer, refractory to radioactive iodine therapy
2021 · E. V. Borodavina, V. V. Krylov, et al. · Head and neck tumors (HNT) · 2
PDF
Personalized therapy with lenvatinib for progressive radioiodine refractory differentiated thyroid cancer in routine clinical practice
2021 · P. O. Rumyantsev, E. V. Borodavina, et al. · Head and neck tumors (HNT) · 2
PDF
The Martinique Principles in Radioiodine Therapy of Differentiated Thyroid Cancer
2020 · T. M. Geliashvili, V. V. Krylov, et al. · Diagnostic radiology and radiotherapy · 2
PDF
The first Russian experience in the use of peptide-receptor radionuclide therapy Lu-177-DOTA-TATE in metastatic neuroendocrine tumors. Analysis of safety and preliminary treatment results
2026 · A.Yu. Shurinov, V.V. Krylov, et al. · Radiation and Risk Bulletin of the National Radiation and Epidemiological Registry · 1
PDF
Features of clinical manifestations of salivary gland pathology in patients after radioiodine therapy
2025 · A.Ya. Razumova, A.I. Yaremenko, et al. · Stomatology · 1
The peptide-receptor radinuclide therapy with radiopharmaceutical 177Lu-DOTA-TATE.
2025 · A. Yu. Shurinov, V. V. Krylov, et al. · Journal of oncology diagnostic radiology and radiotherapy · 1
Selpercatinib in the treatment of medullary and radioiodine-refractory differentiated thyroid cancer with RET mutation (literature review)
2025 · E. V. Borodavina, S. I. Kutukova, et al. · Head and neck tumors (HNT) · 1
Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness
2024 · E. V. Borodavina, S.  I. Kutukova, et al. · Head and neck tumors (HNT) · 1
PDF
Side skin reactions of multikinase inhibitors in treatment of thyroid cancer
2020 · F. S. Sevryukov, E. V. Borodavina, et al. · Head and neck tumors (HNT) · 1
PDF
Tall-cell variant of papillary thyroid carcinoma: literature review and case reports
2020 · E. V. Borodavina, P. A. Isaev, et al. · Head and neck tumors (HNT) · 1
PDF
Clinical case of liver metastasis in 15-year-old adolescent with papillary thyroid carcinoma
2026 · E. V. Borodavina, A. S. Bakhmat, et al. · Russian Journal of Pediatric Hematology and Oncology
PDF
Peptide-receptor radionuclide therapy of 177Lu-DOTA-TATE progressive medullary thyroid cancer. foreign and domestic experience: a review
2026 · E. V. Borodavina, M. А. Sigov, et al. · Diagnostic radiology and radiotherapy
PDF
Possibilities of ultrasound in the diagnosis of radioiodine-induced sialadenitis
2025 · A.Ya. Razumova, N.L. Petrov, et al. · Clinical Dentistry (Russia)
PDF
Advanced metastatic radioiodine refractory differentiated thyroid cancer: current treatment and dynamic surveillance issues
2025 · E. V. Borodavina, A. Yu. Shurinov, et al. · Head and neck tumors (HNT)
Lenvatinib in advanced radioiodine-refractory differentiated thyroid cancer: what’s new?
2025 · E. V. Borodavina, S. I. Kutukova, et al. · Head and neck tumors (HNT)
PDF
Identification of prognostic factors for the development of sialadenitis on the background of radioiodine therapy
2024 · A. Ya. Razumova, S. I. Kutukova, et al. · Medical alphabet
PDF
“Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use
2023 · E. V. Borodavina, A. Yu. Shurinov, et al. · Head and neck tumors (HNT)
PDF
Works count: 37
Citation count: 55
H-index: 4
I10-index: 1
Year
Topic
Type